Coherent Market Insights published a business research report on North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market: Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
The North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4273
Acute bacterial skin and skin structure infections (ABSSSIs), also referred to as skin and soft tissue infections, are infections of skin and associated soft tissues that affect the epidermis, dermis, or subcutaneous tissues. Management of skin and skin structure infections is complex and includes surgical procedures and antibiotic treatment. The therapeutic approaches favored in treating skin infections include wound culture with susceptibility testing, appropriate empiric antibiotic therapy, adjunctive therapies, and surgical drainage and debridement.
The vast majority of ABSSSI patients are men (although some women may contract vaginal infections from having intercourse with an infected male partner). They represent one of the most common indications for antibiotic therapy and are common in Europe and the U.S. Staph bacteria are one of the most common causes of skin infections. Most of these skin infections are minor, are not spread to others (not infectious), and can be treated without antibiotics.
Competitive Landscape:
Major players operating in the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market are Sun Pharmaceutical Industries Ltd., AbbVie Inc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Arrevus, Inc., Melinta Therapeutics, Inc., GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Paratek Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd., among others.
Key Market Drivers:
Increasing number of ABSSSI cases and increasing demand for ABSSSI treatment is expected to augment the growth of the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market during the forecast period. For instance, in January 2022, Paladin Labs Inc. launched Xydalba (dalbavancin for injection), a 30-minute intravenous (IV) therapy for ABSSSI that can be administered as single- or two-dose regimen. Xydalba is now available to patients nationwide in Canada.
Moreover, rising number of product approvals from regulatory bodies is expected to boost the growth of the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market. For instance, in July 2021, AbbVie announced that the U.S. Food and Drug Administration (FDA) approved DALVANCE (dalbavancin) for the treatment of ABSSSI in pediatric patients from birth. DALVANCE is a 30-minute intravenous (IV) therapy for ABSSSI that can be administered as single-dose regimen.
COVID-19 Impact Analysis:
Antibiotic treatment is required for most patients with severe ABSSSI and treatment may be delayed due to the outbreak of COVID-19. Moreover, antibiotic treatment of ABSSSI is being postponed or cancelled due to the unavailability of ABSSSI antibiotics and irregular supply and transportation of products. This in turn is expected to hinder growth of the market.
Key Takeaways:
- The North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market is expected to exhibit a CAGR of 3.9% over the forecast period due to the increasing research and development. For instance, in September 2019, MicuRx Pharmaceuticals, Inc. announced positive top-line results for study MRX4-201, a Phase 2 randomized, double-blind clinical trial of contezolid acefosamil for the treatment of ABSSSI.
- Among regions, North America is expected to witness robust growth in the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market due to the high prevalence of ABSSSI, increasing research and development, and frequent approvals-launches of novel products in the region. For instance, in March 2021, Melinta Therapeutics received the Food and Drug Administration (FDA) approval for KIMYRSA (oritavancin) for the treatment of ABSSSI. KIMYRSA is an antibiotic that delivers a complete course of therapy for ABSSSI in a single, one hour 1,200 mg infusion.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4273
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Industry Impact
Chapter 2 North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Competition by Types, Applications, and Top Regions and Countries
2.1 North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) (Volume and Value) by Type
2.3 North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Conclusions
Research Methodology
Continued….
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4273
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837